Latest News - Valeant NJ

Friday, October 13, 2017 | Personnel/Company News, PracticalDermatology.com, Solta, Valeant NJ

James P. Hartman Tapped as New Vice President and General Manager at Solta Medical

James P. Hartman is the new Vice President and general manager at Solta Medical, a division of Valeant Pharmaceuticals North America LLC. Mr. Hartman joined Solta Medical from Merz Aesthe…

Read the full story

Wednesday, October 04, 2017 | FDA Approval/Clearance, PracticalDermatology.com, Product Launches and Updates, Solta, Valeant NJ

FDA Clears Thermage’s FLX System for Smoothing Skin

The U.S. Food and Drug Administration (FDA) granted 510(K) clearance to Solta Medical’s new Thermage FLXTM System for smoothing skin on the face, eyes, and body. The Thermage FLX fe…

Read the full story

Tuesday, July 18, 2017 | Acquisitions and Mergers, Personnel/Company News, PracticalDermatology.com, Obagi, Valeant NJ

Valeant to Sell Obagi Medical Products Unit for $190 Million

In a deal valued at $190 million in cash, Valeant Pharmaceuticals International, Inc. has entered into an agreement to sell its Obagi Medical Products business to Haitong International Zhong…

Read the full story

Thursday, February 23, 2017 | Personnel/Company News, Product Launches and Updates, Obagi, Valeant NJ

Obagi Teams Up with Suzan Obagi, MD and Nextcell Medical to Introduce New Skincare Line

Obagi Medical Products, a wholly owned subsidiary of Valeant Pharmaceuticals International, Inc., has collaborated with Nextcell Medical Company to claim exclusive distribution of Suzan Obagi, MD&rsqu…

Read the full story

Tuesday, January 10, 2017 | Personnel/Company News, PracticalDermatology.com, Valeant NJ

Valeant Offloads CeraVe, AcneFree And AMBI To L'Oréal

Valeant Pharmaceuticals International, Inc. is selling CeraVe, AcneFree and AMBI skincare brands to L'Oréal for $1.3 billion in cash. The transaction is expected to close in th…

Read the full story

Tuesday, December 13, 2016 | Personnel/Company News, Valeant NJ

Valeant Appoints New EVP, Dermatology

Valeant Pharmaceuticals International, Inc. appointed William D. Humphries as Executive Vice President, Dermatology, effective January 2, 2017.  Mr. Humphries will join Valeant's Executive Co…

Read the full story

Thursday, November 17, 2016 | PracticalDermatology.com, Product Launches and Updates, Valeant NJ

Cerave To Debut New Day Cream, Gel Oil

Cerave is expanding their Renewing product line. A new Cerave Skin Renewing Day Cream with Broad Spectrum SPF 30 sunscreen and Skin Renewing Gel Oil now join existing products in this line includin…

Read the full story